About ProMIS Neurosciences
ProMIS Neurosciences (TSX:PMN), (NASDAQ:PMN) focuses on discovering and developing treatments targeting neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease. This company aims to identify specific epitopes on misfolded proteins which are common in these conditions, leveraging their proprietary technology platforms to create both therapeutic and diagnostic solutions. Their portfolio includes several antibody candidates in preclinical development, designed to target toxic misfolded protein aggregates believed to contribute to the progression of neurodegenerative diseases. The ultimate objective of ProMIS Neurosciences is to halt disease progression and improve the quality of life for patients suffering from these devastating conditions.
Snapshot
Operations
Products and/or services of ProMIS Neurosciences
- Development of precision medicine therapies targeting misfolded proteins implicated in neurodegenerative diseases like Alzheimer's and ALS.
- Research on monoclonal antibodies targeting toxic oligomers for the treatment of ALS and Alzheimer's disease.
- PMN310, an antibody therapy showing high selectivity for toxic amyloid-beta oligomers in Alzheimer's disease.
- Collaboration with pharmaceutical companies to explore therapeutic antibodies for neurodegenerative diseases.
- Diagnostic tools for early detection of biomarkers associated with neurodegenerative diseases.
- Engagement in partnerships for the advancement of research and development in neurodegenerative disease therapies.
ProMIS Neurosciences executive team
- Mr. Eugene W. WilliamsCo-Founder & Chairman
- Mr. Neil K. Warma M.B.A.CEO, President, Compliance Officer & Director
- Dr. Neil R. Cashman M.D.Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
- Mr. Daniel E. Geffken M.B.A.Chief Financial Officer
- Dr. Johanne Kaplan Ph.D.Chief Development Officer
- Dr. David Wishart Ph.D.Chief Physics Officer
- Mr. Dennis Chen Ph.D.Head of Manufacturing & Senior Consultant
- Dr. Larry Douglas Altstiel M.D., Ph.D.Chief Medical Officer